Please try another search
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People’s Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Shiwen Lv | 54 | 2018 | Chairman, CEO & CTO |
Jiaqi Zheng | 40 | 2020 | Non-Executive Director |
Bo Hu | 33 | 2021 | IT Director & Supervisor |
Jing Xu | 34 | 2021 | Chairwoman of Board of Supervisors |
Fei Pan | 38 | - | CFO, VP & Executive Director |
Jiliu Du | 53 | 2022 | Independent Non-Executive Director |
Ching Tan | 58 | 2019 | Non-Executive Director |
Lehe Mei | 58 | 2022 | Independent Non-executive Director |
Xinxing Chen | 37 | 2021 | Non-Executive Director |
Youpei Xie | 53 | 2011 | Non-Executive Director |
Hao Tang | 38 | 2020 | Supervisor |
Shoukang Lin | 60 | 2022 | Independent Non-executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review